- Home
- GATX vs PCVX Comparison
GATX vs PCVX Comparison
Compare GATX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GATX | PCVX |
|---|---|---|
| Founded | 1898 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GATX | PCVX |
|---|---|---|
| Price | $174.07 | $44.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $195.00 | $105.00 |
| AVG Volume (30 Days) | 154.7K | ★ 1.3M |
| Earning Date | 01-22-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ 14.17 | N/A |
| EPS | ★ 8.56 | N/A |
| Revenue | ★ $1,704,900,000.00 | N/A |
| Revenue This Year | $11.64 | N/A |
| Revenue Next Year | $15.03 | N/A |
| P/E Ratio | $20.46 | ★ N/A |
| Revenue Growth | ★ 10.66 | N/A |
| 52 Week Low | $139.44 | $27.66 |
| 52 Week High | $178.26 | $93.77 |
Technical Indicators
Market Signals| Indicator | GATX | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 45.50 |
| Support Level | $168.50 | $43.95 |
| Resistance Level | $175.37 | $47.40 |
| Average True Range (ATR) | 3.12 | 1.78 |
| MACD | -0.16 | -0.18 |
| Stochastic Oscillator | 85.15 | 37.13 |
Price Performance
Historical ComparisonAbout GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.